TQB3006

TQB3006 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3006, covering 2025-05-22 to 2025-05-22. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer [Phase 1]